Upgrade of an old drug: Auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectiveness
Author:
Affiliation:
1. Department of Experimental and Clinical Biomedical Sciences University of Florence Florence Italy
2. Biological Mass Spectrometry and Proteomics Group Plasticité du Cerveau UMR 8249 CNRS Paris ESPCI Paris‐PSL France
Publisher
Wiley
Subject
Drug Discovery,Pharmacology,Molecular Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/med.21872
Reference150 articles.
1. Auranofin;Kean WF;Rheumatology,1997
2. Clinical pharmacology of gold;Kean WF;Inflammopharmacology,2008
3. Auranofin: a preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis;Chaffman M;Drugs,1984
4. Phase I clinical trial results of auranofin, a novel antiparasitic agent;Capparelli EV;Antimicrob Agents Chemother,2016
5. Gold complexes in the treatment of rheumatoid arthritis;Messori L;Met Ions Biol Syst,2004
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Auranofin Suppresses the Growth of Canine Mammary Tumour Cells and Induces Apoptosis via the PI3K/AKT Pathway;Veterinary and Comparative Oncology;2024-09-02
2. Oxidative cell death in cancer: mechanisms and therapeutic opportunities;Cell Death & Disease;2024-08-01
3. Targeting the redox vulnerability of acute myeloid leukaemia cells with a combination of auranofin and vitamin C;British Journal of Haematology;2024-08
4. Exploration of Rhenium Bisquinoline Tricarbonyl Complexes for their Antibacterial Properties;ChemBioChem;2024-07-16
5. Inducing ubiquitination and degradation of TrxR1 protein by LW-216 promotes apoptosis in non-small cell lung cancer via triggering ROS production;Neoplasia;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3